Tarsus Pharmaceuticals (TARS) Loses -15.59% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Tarsus Pharmaceuticals, Inc. (TARS) has been beaten down lately with too much selling pressure. While the stock has lost 15.6% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.
We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.
RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.
Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.
So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefitting from the inevitable rebound.
However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.
The RSI reading of 29.83 for TARS is an indication that the heavy selling could be in the process of exhausting itself, so the stock could bounce back in a quest for reaching the old equilibrium of supply and demand.
This technical indicator is not the only factor that calls for a potential rebound for the stock. There is a fundamental indicator as well. A strong agreement among sell-side analysts covering TARS in raising earnings estimates for the current year has led to an increase in the consensus EPS estimate by 19.5% over the last 30 days. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.
Moreover, TARS currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than the 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Tarsus Pharmaceuticals, Inc. (TARS) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Washington Post
25 minutes ago
- Washington Post
Motorcar Parts: Fiscal Q4 Earnings Snapshot
TORRANCE, Calif. — TORRANCE, Calif. — Motorcar Parts of America Inc. (MPAA) on Monday reported a loss of $722,000 in its fiscal fourth quarter. The Torrance, California-based company said it had a loss of 4 cents per share. Earnings, adjusted for one-time gains and costs, came to 28 cents per share. The maker of remanufactured vehicle alternators and starters posted revenue of $193.1 million in the period. For the year, the company reported a loss of $19.5 million, or 99 cents per share. Revenue was reported as $757.4 million. Motorcar Parts expects full-year revenue in the range of $780 million to $800 million. _____ This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on MPAA at
Yahoo
26 minutes ago
- Yahoo
Rubrik, Inc. (RBRK): A Bull Case Theory
We came across a bullish thesis on Rubrik, Inc. (RBRK) on Deep Value Returns' Substack. In this article, we will summarize the bulls' thesis on RBRK. Rubrik, Inc. (RBRK)'s share was trading at $98.54 as of 4th June. A high-rise office building, its staff busy at work providing cybersecurity services. Rubrik (RBRK) has significantly outpaced expectations, approaching the author's $110 per share target well ahead of the original summer 2026 timeline. While this rapid rally increases the likelihood of a near-term pullback, particularly around earnings as investors look to lock in profits, the recommendation remains to hold the position. The stock's earlier volatility and sharp rebounds underscore the importance of avoiding stop-loss strategies, which might have shaken out long-term investors prematurely. Rubrik's core strength lies in its comprehensive 'cyber resilience' platform, which goes beyond traditional cybersecurity by ensuring companies can quickly recover from attacks. Its unified approach protects data across cloud, on-premises, and popular SaaS applications like Microsoft 365, offering a critical solution as businesses face growing AI-driven data risks. The company's fiscal 2026 guidance, given amid macro uncertainty and market volatility in March, was understandably conservative. Nevertheless, if Rubrik can achieve 45% year-over-year growth, it would significantly bolster confidence in its trajectory toward the $110 target. Although the stock trades at a rich 160x forward free cash flow, the valuation reflects optimism around Rubrik's scalable model. Management delivered an exceptional 29% free cash flow margin in Q4 FY25, but full-year expectations have been tempered to 10%, implying some lumpiness ahead. Still, with a projected free cash flow of $120 million and powerful demand trends in cybersecurity, Rubrik is positioned to grow into its valuation. Despite short-term risks, the structural growth story remains intact, and investors are encouraged to stay patient as the company continues to execute within a high-potential sector. We previously covered a on Rubrik (RBRK) by ElectSamsepi0l on the wallstreetbets Subreddit in December 2024, highlighting its post-IPO momentum, partnerships, and strong ARR growth crossing $1B. The thesis has played out well as the stock price of RBRK has appreciated by roughly 84% since then. Deep Value Returns' June 2025 Substack echoes this optimism but emphasizes Rubrik's accelerating path toward a $110 price target, robust free cash flow margins, and its differentiated cyber resilience platform, framing it as a long-term compounder despite elevated valuation multiples. Rubrik, Inc. (RBRK) is not on our list of the 30 Most Popular Stocks Among Hedge Funds. As per our database, 45 hedge fund portfolios held RBRK at the end of the first quarter which was 41 in the previous quarter. While we acknowledge the risk and potential of RBRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock. Disclosure: None. This article was originally published at Insider Monkey.
Business Wire
27 minutes ago
- Business Wire
D.R. Horton, Inc. Announces Dual Listing on NYSE Texas
ARLINGTON, Texas--(BUSINESS WIRE)-- D.R. Horton, Inc. (NYSE:DHI), America's Builder, announced today the dual listing of its common stock on NYSE Texas, the newly launched fully electronic equities exchange headquartered in Dallas, TX. The Company will maintain its primary listing on the New York Stock Exchange and trade with the same 'DHI' ticker symbol on NYSE Texas. David Auld, Chairman of the Board, said, 'We are pleased to be a Founding Member of NYSE Texas and show our support to the state we have called home for nearly fifty years. We believe Texas's long-standing commitment to pro-growth, business-friendly policies promotes a resilient economy. As the Lone Star State's economy continues to thrive and build momentum, we are committed to contributing in a meaningful way by providing housing to the rapidly growing population of Texas.' 'Based in Texas, D.R. Horton has been the largest homebuilder by volume in the United States for over two decades,' said Chris Taylor, Chief Development Officer, NYSE Group. 'We are proud to welcome the Company to NYSE Texas as a Founding Member.' About D.R. Horton, Inc. D.R. Horton, Inc., America's Builder, has been the largest homebuilder by volume in the United States since 2002 and has closed more than 1,100,000 homes in its 46-year history. D.R. Horton has operations in 126 markets in 36 states across the United States and is engaged in the construction and sale of high-quality homes through its diverse product portfolio with sales prices generally ranging from $250,000 to over $1,000,000. The Company also constructs and sells both single-family and multi-family rental properties. During the twelve-month period ended March 31, 2025, D.R. Horton closed 86,137 homes in its homebuilding operations, in addition to 3,312 single-family rental homes and 2,282 multi-family rental units in its rental operations. D.R. Horton also provides mortgage financing, title services and insurance agency services for its homebuyers and is the majority-owner of Forestar Group Inc., a publicly traded national residential lot development company.
